Add to ORKGThis article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases as bronchial asthma, allergic rhinitis and atopic dermatitis are conditioned by processes based on increase of immunoglobulin e synthesis. Omalizunab, which is a recombinant humanized monoclone anti-Ige antibody, prevents Ige fixing to membrane receptors of mast cells and significantly reduces the level of immunoglobulin e circulating in blood.Key words: anti-Ige antibody, omalizumab, allergic diseases, Bronchial asthma, children
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....
Omalizumab is a humanized monoclonal anti-IgE antibody developed for the treatment of allergic disea...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....
This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases ...
The article describes a modern approach to the use of anti-IgE therapy for allergic bronchial asthma...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
The importance of immunoglobulin E (IgE) in atopic disorders such as asthma, allergic rhinitis, food...
The incidence of allergic diseases is increasing to epidemic proportions both in the developed and d...
Abstract: The importance of immunoglobulin E (IgE) in atopic disorders such as asthma, allergic rhin...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
Omalizumab is a recombinant humanized monoclonal antibody that reduces levels of circulating IgE and...
IgE has long been known as a therapeutic target for allergic disease, but the difficulty has been in...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....
Omalizumab is a humanized monoclonal anti-IgE antibody developed for the treatment of allergic disea...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....
This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases ...
The article describes a modern approach to the use of anti-IgE therapy for allergic bronchial asthma...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
The importance of immunoglobulin E (IgE) in atopic disorders such as asthma, allergic rhinitis, food...
The incidence of allergic diseases is increasing to epidemic proportions both in the developed and d...
Abstract: The importance of immunoglobulin E (IgE) in atopic disorders such as asthma, allergic rhin...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
Omalizumab is a recombinant humanized monoclonal antibody that reduces levels of circulating IgE and...
IgE has long been known as a therapeutic target for allergic disease, but the difficulty has been in...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....
Omalizumab is a humanized monoclonal anti-IgE antibody developed for the treatment of allergic disea...
IgE antibodies are crucially involved in mediating, maintaining and amplifying the allergic cascade....